Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.88 HKD | +0.51% | +2.26% | -2.79% |
Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.79% | 7.88B | |
+12.06% | 68.18B | |
+5.16% | 25.78B | |
+4.48% | 7.99B | |
-23.97% | 7.62B | |
-0.79% | 4.48B | |
+20.68% | 4.45B | |
-4.23% | 3.89B | |
-3.85% | 3.82B | |
+23.62% | 3.69B |
- Stock Market
- Equities
- 1099 Stock
- News Sinopharm Group Co. Ltd.
- Sinopharm's New Drug Found Effective Against Delta, Omicron COVID-19 Strains